SCHEMBL7517448

SCHEMBL7517448

CCOC(C)C(C)C(OCC)OCC

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL358984 0.84 LMNA (0.53) LMNATHRB
SCHEMBL31633561 0.81 LMNA (0.50) LMNATHRB
SCHEMBL14615983 0.79 LMNA (0.47) LMNATHRB
SCHEMBL16356371 0.79 LMNA (0.47) LMNATHRB
SCHEMBL28948866 0.79 LMNA (0.47) LMNATHRB
SCHEMBL7730742 0.77 LMNA (0.60) LMNATHRB
SCHEMBL8588637 0.77 LMNA (0.45) LMNATHRB
SCHEMBL8589179 0.77 LMNA (0.45) LMNATHRB
SCHEMBL22534482 0.74 LMNA (0.43) LMNATHRB
SCHEMBL20464017 0.74 LMNA (0.43) LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2799420-B1 METHOD FOR SYNTHESIZING 2,7-DIMETHYL-2,4,6-OCTATRIENE-1,8-DIALDEHYDE NANJING UNIVERSITY OF TECHNOLOGY (CN) 2016-11-16 EP claimed
US-9187394-B2 Method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde NANJING UNIVERSITY OF TECHNOLOGY (CN) 2015-11-17 US claimed
US-20140378711-A1 METHOD FOR SYNTHESIZING 2,7-DIMETHYL-2,4,6-OCTATRIENE-1,8-DIALDEHYDE NANJING UNIVERSITY OF TECHNOLOGY (CN) 2014-12-25 US claimed
EP-2799420-A1 METHOD FOR SYNTHESIZING 2,7-DIMETHYL-2,4,6-OCTATRIENE-1,8-DIALDEHYDE Nanjing University Of Technology (CN) 2014-11-05 EP claimed
CN-103172504-B Synthesis method of 2, 7-dimethyl-2, 4, 6-octatriene-1, 8-dialdehyde NANJING TECH UNIVERSITY (CN) 2014-10-08 CN claimed
CN-103172504-A Synthesis method of 2, 7-dimethyl-2, 4, 6-octatriene-1, 8-dialdehyde NANJING UNIVERSITY OF TECHNOLOGY 2013-06-26 CN claimed
US-10023589-B2 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators HOFFMANN-LA ROCHE INC. (US) 2018-07-17 US disclosed
EP-2799420-B1 METHOD FOR SYNTHESIZING 2,7-DIMETHYL-2,4,6-OCTATRIENE-1,8-DIALDEHYDE NANJING UNIVERSITY OF TECHNOLOGY (CN) 2016-11-16 EP disclosed
US-20160207936-A1 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS HOFFMANN-LA ROCHE INC. 2016-07-21 US disclosed
US-9255110-B2 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators ROCHE PALO ALTO LLC (US) 2016-02-09 US disclosed
US-9187394-B2 Method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde NANJING UNIVERSITY OF TECHNOLOGY (CN) 2015-11-17 US disclosed
US-9187394-B2 Method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde NANJING UNIVERSITY OF TECHNOLOGY (CN) 2015-11-17 US disclosed
US-9187394-B2 Method for synthesizing 2,7-dimethyl-2,4,6-octatriene-1,8-dialdehyde NANJING UNIVERSITY OF TECHNOLOGY (CN) 2015-11-17 US disclosed
US-5929288-A A POLYENE O,O-DIALKYL ACETAL OR POLYENE DI(O,O-DIALKYL ACETAL) IS REACTED WITH A 1-ALKOXY-1,3-DIENE IN THE PRESENCE OF A LEWIS ACID OR A BRONSTED ACID. THE REACTION MIXTURE IS THEN HYDROLYZED AND THE ALCOHOL IS CLEAVED UNDER BASIC CONDITIONS. ROCHE VITAMINS INC. (US) 1999-07-27 US disclosed
EP-0919547-A1 Preparation of polyenaldehydes F. HOFFMANN-LA ROCHE AG (CH) 1999-06-02 EP disclosed
US-5786518-A HALOHYDROXYLATION OF ALKOXY-2-METHYL-1,3-BUTADIENE WITH ALKANOL AND HALOGEN THEN HYDROLYSIS ROCHE VITAMINS INC. (US) 1998-07-28 US disclosed
CN-1178783-A Preparation method of gamma-tiglic aldehyde HOFFMANN LA ROCHE (CH) 1998-04-15 CN disclosed
EP-0825168-A2 Preparation of gamma-halotiglinaldehydes F. HOFFMANN-LA ROCHE AG (CH) 1998-02-25 EP disclosed
CN-1170708-A Manufacture of polyene (Di) aldehydes HOFFMANN LA ROCHE (CH) 1998-01-21 CN disclosed
EP-0816334-A1 Preparation of polyenic (di)aldehydes F. HOFFMANN-LA ROCHE AG (CH) 1998-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160207936-A1 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS IRAK4, IRAK1, IRAK2 LMNA 2020/4885THRB 712/4885
US-10023589-B2 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators IRAK4, IRAK1, IRAK2 LMNA 2020/4885THRB 712/4885
US-20140378711-A1 METHOD FOR SYNTHESIZING 2,7-DIMETHYL-2,4,6-OCTATRIENE-1,8-DIALDEHYDE TMT1A, DIMT1, TET1 LMNA 3731/4885THRB 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.